These problems should not occur when using Sos1-specific inhibitors, as inferred by the viability shown by mice lacking Sos1 in postnatal periods (Baltanás et al., 2013) . Regardless of these potential caveats, this work highlights the feasibility of isolating Ras GEF-specific inhibitors, opens the door to new therapeutic opportunities in Sosdependent diseases, and provides a valuable tool to further address Sos function in cells. (B) Binding sites of inhibitory (site a, red) and stimulatory (site b, brown) com-pounds of Sos1 enzyme activity in one of the subregions of the Sos1 catalytic site. Sos1 residues potentially involved in the interaction with these com-pounds are shown in stick form and labeled. The Ras switch II region is shown in blue. The Sos1 aH helix that gets into a cleft between the switch regions and that is critical for the exchange reaction is not shown. N and C, N-and C-termini of the Sos1 fragment shown.
